Search research articles
Contact Us
Filters
Showing results (81-90 of 155) with videos related to
Page
of 16
Sort By:
Dalton Transactions (Cambridge, England : 2003)
|
December 18, 2010
Antiproliferative activity of chelating N,O- and N,N-ruthenium(II) arene functionalised poly(propyleneimine) dendrimer scaffolds
Preshendren Govender, Anna K Renfrew, Catherine M Clavel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Pharmacokinetically guided dosing for intravenous melphalan: a pilot study in patients with advanced ovarian adenocarcinoma
D Y Ploin, B Tranchand, J P Guastalla, et al.
Cancer
|
November 1, 1990
Toxic dermatitis induced by 10-ethyl-10-deaza-aminopterin (10-EdAM), a novel antifolate
J Verweij, J Schornagel, P de Mulder, et al.
Journal of Medicinal Chemistry
|
March 28, 2014
Discovery of a highly tumor-selective organometallic ruthenium(II)-arene complex
Catherine M Clavel, Emilia Păunescu, Patrycja Nowak-Sliwinska, et al.
Chemmedchem
|
July 21, 2015
Anticancer Organometallic Osmium(II)-p-cymene Complexes
Emilia Păunescu, Patrycja Nowak-Sliwinska, Catherine M Clavel, et al.
European Journal of Cancer & Clinical Oncology
|
April 1, 1987
Phase II study of iproplatin (CHIP, JM-9) in advanced squamous cell carcinoma of the head and neck
R Abele, M Clavel, S Monfardini, et al.
Dalton Transactions (Cambridge, England : 2003)
|
November 13, 2012
The influence of RAPTA moieties on the antiproliferative activity of peripheral-functionalised poly(salicylaldiminato) metallodendrimers
Preshendren Govender, Lara C Sudding, Catherine M Clavel, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1982
Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study
J H Mulder, P Dodion, F Cavalli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1993
Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data Center
J B Vermorken, S Gundersen, M Clavel, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1988
Phase II study of TCNU in advanced breast cancer
P Dombernowsky, M Clavel, J F Smyth, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 155) with videos related to
Sort By:
Page
of 16
Dalton Transactions (Cambridge, England : 2003)
|
December 18, 2010
Antiproliferative activity of chelating N,O- and N,N-ruthenium(II) arene functionalised poly(propyleneimine) dendrimer scaffolds
Preshendren Govender, Anna K Renfrew, Catherine M Clavel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Pharmacokinetically guided dosing for intravenous melphalan: a pilot study in patients with advanced ovarian adenocarcinoma
D Y Ploin, B Tranchand, J P Guastalla, et al.
Cancer
|
November 1, 1990
Toxic dermatitis induced by 10-ethyl-10-deaza-aminopterin (10-EdAM), a novel antifolate
J Verweij, J Schornagel, P de Mulder, et al.
Journal of Medicinal Chemistry
|
March 28, 2014
Discovery of a highly tumor-selective organometallic ruthenium(II)-arene complex
Catherine M Clavel, Emilia Păunescu, Patrycja Nowak-Sliwinska, et al.
Chemmedchem
|
July 21, 2015
Anticancer Organometallic Osmium(II)-p-cymene Complexes
Emilia Păunescu, Patrycja Nowak-Sliwinska, Catherine M Clavel, et al.
European Journal of Cancer & Clinical Oncology
|
April 1, 1987
Phase II study of iproplatin (CHIP, JM-9) in advanced squamous cell carcinoma of the head and neck
R Abele, M Clavel, S Monfardini, et al.
Dalton Transactions (Cambridge, England : 2003)
|
November 13, 2012
The influence of RAPTA moieties on the antiproliferative activity of peripheral-functionalised poly(salicylaldiminato) metallodendrimers
Preshendren Govender, Lara C Sudding, Catherine M Clavel, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1982
Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study
J H Mulder, P Dodion, F Cavalli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1993
Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data Center
J B Vermorken, S Gundersen, M Clavel, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1988
Phase II study of TCNU in advanced breast cancer
P Dombernowsky, M Clavel, J F Smyth, et al.
Page
of 16